doi: 10.3389/fimmu.2026.1737847 Received 02 November 2025 Revised 09 January 2026 Accepted 12 January 2026 Published 30 January 2026 Volume 17 - 2026 Edited by Ana Carolina Martinez-Torres, Autonomous University of Nuevo Len, Mexico Reviewed by Karla Alvarez-Valadez, INSERM U1138 Centre de Recherche des Cordeliers (CRC), France Helen Yarimet Lorenzo-Anota, University of Technology Compiegne, France Updates Copyright 2026 Guo, Wang, Zhang, Xie, Chen, Ma, Guo and Zhang
This is why CJC-1295 no DAC is also known as tetrasubstituted GRF (1-29), modified GRF (1-29) or simply mod GRF (1-29) [10]
To address this issue, the sources of controversies previously described should be resolved specifically before the potential application of sKlotho as a biomarker in CKD
El CJC-1295 no DAC es un pptido anlogo de la hormona liberadora de hormona de crecimiento (GHRH)
Their history suggests degenerative disc disease of the thoracic spine with radiculopathy as the reason for chronic lower back pain
Dietary factors, hormesis and health